Roche Sees Continued Emerging Markets Strength Despite Slowdown
This article was originally published in PharmAsia News
Executive Summary
As it reported a generally strong third quarter, Roche has said it foresees continued strength in China and other emerging markets, driven by the value of its products and despite a general growth slowdown over the past year.